Relapsed Lymphomas
Also known as: Relapsed Lymphoma
Drug | Drug Name | Drug Description |
---|---|---|
DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB01204 | Mitoxantrone | DNA topoisomerase 2-alpha | target |
DB01204 | Mitoxantrone | Cytochrome P450 2E1 | enzyme |
DB01204 | Mitoxantrone | P-glycoprotein 1 | transporter |
DB01204 | Mitoxantrone | Multidrug resistance-associated protein 1 | transporter |
DB01204 | Mitoxantrone | ATP-binding cassette sub-family G member 2 | transporter |
DB01204 | Mitoxantrone | DNA | target |
DB01204 | Mitoxantrone | Cytochrome P450 1B1 | enzyme |
DB01204 | Mitoxantrone | Cytochrome P450 3A4 | enzyme |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11891 | Fimepinostat | 1 | Completed | 1 |
DB00073 | Rituximab | 1 | Completed | 1 |
DB11581 | Venetoclax | 1 | Completed | 1 |
DB00997 | Doxorubicin | 1 / 2 | Terminated | 1 |
DB02546 | Vorinostat | 1 / 2 | Terminated | 1 |
DB05260 | Gallium nitrate | 2 | Completed | 1 |